Search in:

Neuropsychiatric Disease and Treatment Volume 5, 2009 - Issue

Views

CrossRef citations to date

Altmetric

Case Report

Aripiprazole in the treatment of Huntington’s disease: a case series

Andrea Ciammola1 Department of Neurology and Laboratory of Neuroscience, “Dino Ferrari” Centre, University of Milan Medical School – IRCCS Istituto Auxologico Italiano, Milano, ItalyCorrespondence[email protected]

Jenny Sassone1 Department of Neurology and Laboratory of Neuroscience, “Dino Ferrari” Centre, University of Milan Medical School – IRCCS Istituto Auxologico Italiano, Milano, Italy

Clarissa Colciago1 Department of Neurology and Laboratory of Neuroscience, “Dino Ferrari” Centre, University of Milan Medical School – IRCCS Istituto Auxologico Italiano, Milano, Italy

Niccolò E Mencacci1 Department of Neurology and Laboratory of Neuroscience, “Dino Ferrari” Centre, University of Milan Medical School – IRCCS Istituto Auxologico Italiano, Milano, Italy

Barbara Poletti1 Department of Neurology and Laboratory of Neuroscience, “Dino Ferrari” Centre, University of Milan Medical School – IRCCS Istituto Auxologico Italiano, Milano, Italy

Andrea Ciarmiello2 Unit of Nuclear Medicine, S. Andrea Hospital, La Spezia, Italy

Ferdinando Squitieri3 Neurogenetics Unit, IRCCS Neuromed, Pozzilli (IS), Italy

Vincenzo Silani1 Department of Neurology and Laboratory of Neuroscience, “Dino Ferrari” Centre, University of Milan Medical School – IRCCS Istituto Auxologico Italiano, Milano, Italy

show all

Pages 1-4 | Published online: 25 Nov 2022

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

References

AdamORJankovicJSymptomatic treatment of Huntington diseaseNeurotherapeutics2008518119718394562
PubMed Web of Science ®Google Scholar
BonelliRMHofmannPA systematic review of the treatment studies in Huntington’s disease since 1990Expert Opin Pharmacother2007814115317257085
PubMed Web of Science ®Google Scholar
RoosRABurumaOJBruynGWKempBvan der VeldeEATiapride in the treatment of Huntington’s choreaActa Neurol Scand19826545506461156
PubMed Web of Science ®Google Scholar
ParsaMASzigethyEVociJMMeltzerHYRisperidone in treatment of choreoathetosis of Huntington’s diseaseJ Clin Psychopharmacol19971713413510950488
PubMed Web of Science ®Google Scholar
MadhusoodananSBrennerRUse of risperidone in psychosis associated with Huntington’s diseaseAm J Geriatr Psychiatry199863473499793585
PubMed Web of Science ®Google Scholar
DallocchioCBuffaCTinelliCMazzarelloPEffectiveness of risperidone in Huntington chorea patientsJ Clin Psychopharmacol1999191011039934953
PubMed Web of Science ®Google Scholar
ErdemogluAKBoratavCRisperidone in chorea and psychosis of Huntington’s diseaseEur J Neurol2002918218311882064
PubMed Web of Science ®Google Scholar
DuffKBeglingerLJO’RourkeMENopoulosPPaulsonHLPaulsenJSRisperidone and the treatment of psychiatric, motor, and cognitive symptoms in Huntington’s diseaseAnn Clin Psychiatry2008201318297579
PubMed Web of Science ®Google Scholar
SquitieriFCannellaMPiorcelliniABrusaLSimonelliMRuggieriSShort-term effects of olanzapine in Huntington diseaseNeuropsychiatry Neuropsychol Behav Neurol200114697211234911
PubMedGoogle Scholar
BonelliRMMahnertFANiederwieserGOlanzapine for Huntington’s disease: an open label studyClin Neuropharmacol20022526326512410058
PubMed Web of Science ®Google Scholar
NewcomerJWSecond-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature reviewCNS Drugs200519Suppl 119315998156
PubMed Web of Science ®Google Scholar
LiebermanJAAripiprazoleSchatzbergAFNemeroffCBThe American Psychiatric Publishing Textbook of Psychopharmacology3rd edWashington DC and London UKAmerican Psychiatric Publishing2004407494
Google Scholar
GardnerDMBaldessariniRJWaraichPModern antipsychotic drugs: a critical overviewCMAJ20051721703171115967975
PubMed Web of Science ®Google Scholar
KaneJMCarsonWHSahaAREfficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorderJ Clin Psychiatry20026376377112363115
PubMed Web of Science ®Google Scholar
PigottTACarsonWHSahaARTorbeynsAFStockEGIngenitoGGAripiprazole Study GroupAripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week studyJ Clin Psychiatry2003641048105614628980
PubMed Web of Science ®Google Scholar
Huntington Study GroupUnified Huntington’s Disease Rating Scale: reliability and consistencyMov Disord1996111361428684382
PubMed Web of Science ®Google Scholar
BeckATWardCHMendelsonMMockJErbaughJAn inventory for measuring depressionArch Gen Psychiatry196145363
Web of Science ®Google Scholar
CiammolaASassoneJSquitieriFAripiprazole in Huntington’s disease: A first case report. Editors Movement DisordersProceeding of the Movement Disorder Society’s Eleventh International Congress of Parkinson’s Disease and Movement Disorders; 2007 June 3–7; Istanbul, Turkey200722Suppl 16S27
Google Scholar
ShapiroDARenockSArringtonEAripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacologyNeuropsychopharmacology2003281400141112784105
PubMed Web of Science ®Google Scholar
BurrisKDMolskiTFXuCAripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptorsJ Pharmacol Exp Ther200230238138912065741
PubMed Web of Science ®Google Scholar
Van VugtJPPSieslingSVergeerMvan der VeldeEARoosRAClozapine versus placebo in Huntington’s disease: a double blind randomised comparative studyJ Neurol Neurosurg Psychiatry19976335399221965
PubMed Web of Science ®Google Scholar
ChrzanowskiWKMarcusRNTorbeynsANyilasMMcQuadeRDEffectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapinePsychopharmacology (Berl)200618925926617058105
PubMed Web of Science ®Google Scholar
MeltzerHYThe role of serotonin in antipsychotic drug actionNeuropsychopharmacology199921Suppl 2106115
Web of Science ®Google Scholar
MillianMJImproving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptorsJ Pharmacol Exp Ther200029585386111082417
PubMed Web of Science ®Google Scholar
JordanSKoprivicaVChenRTottoriKKikuchiTAltarCAThe antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptorEur J Pharmacol200244113714012063084
PubMed Web of Science ®Google Scholar
McQuadeRDStockEMarcusRComparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind studyJ Clin Psychiatry200465Suppl 18475615600384
PubMed Web of Science ®Google Scholar
Huntington Study GroupTetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trialNeurology20066636637216476934
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Aripiprazole in the treatment of Huntington’s disease: a case series

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Aripiprazole in the treatment of Huntington’s disease: a case series

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date